Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-07

Clinical Trial Update: Efficacy and Safety of AngongNiuhuang Pill for the Treatment of Patients With Acute Ischemic Stroke. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the efficacy and safety of AngongNiuhuang Pill for acute ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Angongniuhuang Pill

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Acute Ischemic Stroke | Phase 3 | Status: UNKNOWN